NewcelX Ltd. Ordinary Shares (NCEL)
Stock · NASDAQ · Health Care
$3.19as of 8/28/2026
Price chart
Open in TradingViewActive signals
Resistance level
$3.21
Industry
Biotechnology: Pharmaceutical Preparations
About NCEL
NewcelX Ltd., a biopharmaceutical company, engages in developing transformative stem-cell-derived therapies for Diabetes. The company develops NCEL-101, a cellular therapy product based on enriched pancreatic islet-like clusters for the treatment of Type 1 diabetes and Type 2 insulin dependent diabetes; AstroRx, an off-the-shelf cryopreserved cell therapy product for the treatment of Amyotrophic Lateral Sclerosis and…
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Employees
- 9
- Website
- nlspharma.com/
Fundamentals
- 1-day range
- $3.17$3.39
- Market cap
- $17.98M
- P/E (trailing)
- —
- P/E (forward)
- -5.42
- EPS (trailing)
- $-6.38
- Dividend yield
- —
- Beta
- 0.97
- Avg. volume
- 36.6K
52-week range
$1.83$24.6
Forecasts
1 analyst ratings
Buy 86%
Hold 14%
Sell 0%
1-year price forecast
High
$23
+621.0%
Median
$23
+621.0%
Low
$23
+621.0%
NewcelX Ltd. Ordinary Shares Competitors
Chosen by industry and closest market cap.
- NCELNewcelX Ltd. Ordinary Shares$3.19▼ 6.73%Market cap $17.98MP/E —$1.83$24.6
- LPCNLipocine Inc. Common Stock$2.2▼ 1.35%Market cap $17.56MP/E —$1.81$12.37
- MRKRMarker Therapeutics Inc. Common Stock$1.37▼ 7.12%Market cap $18.67MP/E —$0.8099$2.46
- NRSNNeuroSense Therapeutics Ltd. Ordinary Shares$0.4301▼ 2.03%Market cap $19.00MP/E —$0.25$1.98
- CYCNCyclerion Therapeutics Inc. Common Stock$3.81▼ 4.51%Market cap $16.67MP/E —$1.03$8.48
- OPTHOptimi Health Corp. Common Shares$4.93▼ 0.80%Market cap $16.61MP/E —$0.195$11.4
- SKYESkye Bioscience Inc. Common Stock$1.81▼ 7.18%Market cap $16.58MP/E —$1.84$39.92
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| NCEL NewcelX Ltd. Ordinary Shares | $17.98M | — | $3.19 | ▼ 6.73% | $1.83$24.6 |
| LPCN Lipocine Inc. Common Stock | $17.56M | — | $2.2 | ▼ 1.35% | $1.81$12.37 |
| MRKR Marker Therapeutics Inc. Common Stock | $18.67M | — | $1.37 | ▼ 7.12% | $0.8099$2.46 |
| NRSN NeuroSense Therapeutics Ltd. Ordinary Shares | $19.00M | — | $0.4301 | ▼ 2.03% | $0.25$1.98 |
| CYCN Cyclerion Therapeutics Inc. Common Stock | $16.67M | — | $3.81 | ▼ 4.51% | $1.03$8.48 |
| OPTH Optimi Health Corp. Common Shares | $16.61M | — | $4.93 | ▼ 0.80% | $0.195$11.4 |
| SKYE Skye Bioscience Inc. Common Stock | $16.58M | — | $1.81 | ▼ 7.18% | $1.84$39.92 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- 12 Health Care Stocks Moving In Thursday's Pre-Market SessionBenzinga · 8/27/2026
- 12 Health Care Stocks Moving In Friday's Pre-Market SessionBenzinga · 8/14/2026
- NewcelX Announces Pricing of $1.4 Million Equity Financing at 20% Premium PricingYahoo · 7/31/2026
Insider Activity
Insider Actions →Acquired
327.3K
Disposed
0
- Olivier Samuel · April 27, 2026 · Buy114.5K
- Olivier Samuel · April 27, 2026 · Buy81.8K @ $2.75
- Michel Revel · April 27, 2026 · Buy76.4K
- Michel Revel · April 27, 2026 · Buy54.5K @ $2.75
See the full, filterable feed with live charts on the MarketWall dashboard.